Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

1.

Factors influencing the occupational trajectory of patients with systemic sclerosis: a qualitative study.

Decuman S, Smith V, Grypdonck M, De Keyser F, Verhaeghe S.

Clin Exp Rheumatol. 2015 Mar 20. [Epub ahead of print]

PMID:
25797634
2.

Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.

Mulliez SM, De Keyser F, Verbist C, Vantilborgh A, Wijns W, Beukinga I, Devreese KM.

Lupus. 2015 Jun;24(7):736-45. doi: 10.1177/0961203314558859. Epub 2014 Nov 12.

PMID:
25391540
3.

Work participation in patients with systemic sclerosis: a systematic review.

Decuman S, Smith V, Verhaeghe ST, Van Hecke A, De Keyser F.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-206-13. Epub 2014 Nov 5.

PMID:
25372803
4.

Assessment of activity limitations with the health assessment questionnaire predicts the need for support measures in patients with rheumatoid arthritis: a multicenter observational study.

Janssens X, Decuman S, De Keyser F; Belgian Rheumatoid Arthritis Disability Assessment Study Group.

PLoS One. 2014 Sep 4;9(9):e106749. doi: 10.1371/journal.pone.0106749. eCollection 2014.

5.

Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry.

De Keyser F, Hoffman I, Durez P, Kaiser MJ, Westhovens R; MIRA Study Group.

J Rheumatol. 2014 Sep;41(9):1761-5. doi: 10.3899/jrheum.131279. Epub 2014 Aug 15.

PMID:
25128506
6.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, GarcĂ­a-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

7.

Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.

De Keyser E, De Keyser F, De Baets F.

Acta Clin Belg. 2014 Oct;69(5):358-66. doi: 10.1179/2295333714Y.0000000043. Epub 2014 Jul 14.

PMID:
25018132
8.

Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort study.

De Keyser F, De Kock J, Leroi H, Durez P, Westhovens R; Infliximab EAP Study Group.

J Rheumatol. 2014 Jul;41(7):1276-81. doi: 10.3899/jrheum.131270. Epub 2014 Jun 1.

PMID:
24882838
9.

Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al.

Bonroy C, Verfaillie C, De Witte E, De Keyser F.

Arthritis Rheumatol. 2014 Feb;66(2):479-80. doi: 10.1002/art.38252. No abstract available.

PMID:
24504822
10.

Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.

Lambrecht S, Smith V, De Wilde K, Coudenys J, Decuman S, Deforce D, De Keyser F, Elewaut D.

Arthritis Rheumatol. 2014 Feb;66(2):418-27. doi: 10.1002/art.38241.

PMID:
24504814
11.

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR.

N Engl J Med. 2014 Jan 30;370(5):433-43. doi: 10.1056/NEJMoa1114576. Epub 2013 Dec 18.

12.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. Epub 2013 Oct 15.

PMID:
24128778
13.

Cancer risk in immune-mediated inflammatory diseases (IMID).

Beyaert R, Beaugerie L, Van Assche G, Brochez L, Renauld JC, Viguier M, Cocquyt V, Jerusalem G, Machiels JP, Prenen H, Masson P, Louis E, De Keyser F.

Mol Cancer. 2013 Aug 29;12(1):98. doi: 10.1186/1476-4598-12-98. Review.

14.
15.

The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategies.

Bonroy C, Smith V, Van Steendam K, Van Praet J, Deforce D, Devreese K, De Keyser F.

Clin Chem Lab Med. 2013 Nov;51(11):2151-60. doi: 10.1515/cclm-2013-0211.

PMID:
23863700
16.

The influence of ageing on the development and management of rheumatoid arthritis.

Boots AM, Maier AB, Stinissen P, Masson P, Lories RJ, De Keyser F.

Nat Rev Rheumatol. 2013 Oct;9(10):604-13. doi: 10.1038/nrrheum.2013.92. Epub 2013 Jun 18. Review.

PMID:
23774902
17.

Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation.

Bonroy C, Verfaillie C, Smith V, Persijn L, De Witte E, De Keyser F, Devreese K.

Clin Chem Lab Med. 2013 Sep;51(9):1771-9. doi: 10.1515/cclm-2013-0016. Erratum in: Clin Chem Lab Med. 2014 Nov;52(11):1677.

PMID:
23612554
18.

Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines.

Tavares Da Silva F, De Keyser F, Lambert PH, Robinson WH, Westhovens R, Sindic C.

Vaccine. 2013 Apr 3;31(14):1870-6. doi: 10.1016/j.vaccine.2013.01.042. Epub 2013 Feb 4.

19.

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

Smith V, Piette Y, van Praet JT, Decuman S, Deschepper E, Elewaut D, De Keyser F.

J Rheumatol. 2013 Jan;40(1):52-7. doi: 10.3899/jrheum.120778. Epub 2012 Nov 1.

PMID:
23118116
20.

The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.

Vanthuyne M, Smith V, De Langhe E, Van Praet J, Arat S, Depresseux G, Westhovens R, Blockmans D, Badot V, Cogan E, De Keyser F, Houssiau FA.

J Rheumatol. 2012 Nov;39(11):2127-33. doi: 10.3899/jrheum.120283. Epub 2012 Sep 15.

PMID:
22984273
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk